• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化 COVID-19 疫苗接种对我们未来前景的重要性。

Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.

机构信息

Department of Health Sciences Research, Mayo Clinic, Rochester, MN.

Department of Health Sciences Research, Mayo Clinic, Rochester, MN.

出版信息

Mayo Clin Proc. 2021 Jul;96(7):1890-1895. doi: 10.1016/j.mayocp.2021.04.012. Epub 2021 Apr 27.

DOI:10.1016/j.mayocp.2021.04.012
PMID:34218862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8075811/
Abstract

Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made publicly available, has informed Mayo Clinic practice leadership at all sites across the United States and has been shared with Minnesota governmental leadership to help inform critical decisions during the past year. One key to the accuracy of the Mayo Clinic model is its ability to adapt to the constantly changing dynamics of the pandemic and uncertainties of human behavior, such as changes in the rate of contact among the population over time and by geographic location and now new virus variants. The Mayo Clinic model can also be used to forecast COVID-19 trends in different hypothetical worlds in which no vaccine is available, vaccinations are no longer being accepted from this point forward, and 75% of the population is already vaccinated. Surveys indicate that half of American adults are hesitant to receive a COVID-19 vaccine, and lack of understanding of the benefits of vaccination is an important barrier to use. The focus of this paper is to illustrate the stark contrast between these 3 scenarios and to demonstrate, mathematically, the benefit of high vaccine uptake on the future course of the pandemic.

摘要

预测模型在应对 COVID-19 大流行的本地、国家和国际反应中发挥了关键作用。在美国,医疗保健系统和政府机构依赖于多种模型,如健康计量与评估研究所、Youyang Gu(YYG)、麻省理工学院和疾病控制与预防中心综合模型,以预测疾病活动的短期和长期趋势。最近公开的梅奥诊所贝叶斯 SIR 模型为美国各地的梅奥诊所实践领导层提供了信息,并与明尼苏达州政府领导层共享,以帮助在过去一年中做出关键决策。梅奥诊所模型准确性的一个关键是它能够适应大流行不断变化的动态和人类行为的不确定性,例如随着时间的推移和地理位置的变化,人群之间的接触率的变化,以及现在新的病毒变体。该模型还可以用于预测在不同假设世界中 COVID-19 的趋势,在这些假设世界中,没有疫苗可用,从现在开始不再接受疫苗接种,并且 75%的人口已经接种了疫苗。调查表明,一半的美国成年人对接种 COVID-19 疫苗犹豫不决,对疫苗接种益处的缺乏理解是使用疫苗的一个重要障碍。本文的重点是说明这 3 种情况之间的鲜明对比,并从数学上证明高疫苗接种率对大流行未来进程的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/8075811/d27c1eccaa0a/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/8075811/fc0126dd3bb4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/8075811/8f6a044c8fa0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/8075811/41b275ab577f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/8075811/d27c1eccaa0a/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/8075811/fc0126dd3bb4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/8075811/8f6a044c8fa0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/8075811/41b275ab577f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/8075811/d27c1eccaa0a/gr4_lrg.jpg

相似文献

1
Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.量化 COVID-19 疫苗接种对我们未来前景的重要性。
Mayo Clin Proc. 2021 Jul;96(7):1890-1895. doi: 10.1016/j.mayocp.2021.04.012. Epub 2021 Apr 27.
2
Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021.基于疫苗接种率和非药物干预情景的未来 COVID-19 病例、住院和死亡建模-美国,2021 年 4 月至 9 月。
MMWR Morb Mortal Wkly Rep. 2021 May 14;70(19):719-724. doi: 10.15585/mmwr.mm7019e3.
3
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.Covid-19 疫苗在门诊和住院治疗环境中的有效性。
N Engl J Med. 2021 Oct 7;385(15):1355-1371. doi: 10.1056/NEJMoa2110362. Epub 2021 Sep 8.
4
Short-Range Forecasting of COVID-19 During Early Onset at County, Health District, and State Geographic Levels Using Seven Methods: Comparative Forecasting Study.使用七种方法在县、卫生区和州地理级别对 COVID-19 进行早期发病的短期预测:比较预测研究。
J Med Internet Res. 2021 Mar 23;23(3):e24925. doi: 10.2196/24925.
5
Leveraging 13 million responses to the U.S. COVID-19 Trends and Impact Survey to examine vaccine hesitancy, vaccination, and mask wearing, January 2021-February 2022.利用美国 COVID-19 趋势和影响调查的 1300 万份回应,来研究 2021 年 1 月至 2022 年 2 月期间的疫苗犹豫、接种和戴口罩情况。
BMC Public Health. 2022 Oct 13;22(1):1911. doi: 10.1186/s12889-022-14286-3.
6
Changes in general and COVID-19 vaccine hesitancy among U.S. adults from 2021 to 2022.2021 年至 2022 年美国成年人对一般疫苗和 COVID-19 疫苗犹豫的变化。
Ann Med. 2024 Dec;56(1):2357230. doi: 10.1080/07853890.2024.2357230. Epub 2024 May 30.
7
Social inequalities and the early provision and dispersal of COVID-19 vaccinations in the United States: A population trends study.社会不平等与美国 COVID-19 疫苗的早期供应和分发:一项人口趋势研究。
Vaccine. 2023 Aug 14;41(36):5322-5329. doi: 10.1016/j.vaccine.2023.07.022. Epub 2023 Jul 16.
8
Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings.为高危产科患者提供现场 COVID-19 疫苗接种:初步发现。
Am J Obstet Gynecol MFM. 2021 Nov;3(6):100478. doi: 10.1016/j.ajogmf.2021.100478. Epub 2021 Sep 2.
9
Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.异源疫苗接种干预措施以降低大流行的发病率和死亡率:模拟美国 2020 年冬季 COVID-19 浪潮。
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3). doi: 10.1073/pnas.2025448119.
10
Identifying health centers in areas with low COVID-19 vaccination rates & high rates of vaccine hesitancy.识别新冠疫苗接种率低且疫苗犹豫率高地区的卫生中心。
Ann Fam Med. 2022 Apr 1;20(20 Suppl 1):2734. doi: 10.1370/afm.20.s1.2734.

引用本文的文献

1
Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.预测 SARS-CoV-2 导致的健康结果的模型,包括疫苗接种的效果:系统评价。
Syst Rev. 2024 Jan 16;13(1):30. doi: 10.1186/s13643-023-02411-1.
2
Attitudes and Beliefs around the Value of Vaccination in the United States.美国民众对疫苗接种价值的态度与信念
Vaccines (Basel). 2022 Sep 5;10(9):1470. doi: 10.3390/vaccines10091470.
3
Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.

本文引用的文献

1
Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening.新型冠状病毒病 2019(COVID-19)疫苗对接受 COVID-19 分子筛查前无症状感染患者的影响。
Clin Infect Dis. 2022 Jan 7;74(1):59-65. doi: 10.1093/cid/ciab229.
2
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.尽管血清阳性率很高,巴西玛瑙斯仍出现新冠病毒的卷土重来。
Lancet. 2021 Feb 6;397(10273):452-455. doi: 10.1016/S0140-6736(21)00183-5. Epub 2021 Jan 27.
3
What we know about covid-19 reinfection so far.
城市层面 COVID-19 上市疫苗效力的监测、评估和应用:基于健康码区块链的研究。
BMJ Open. 2022 Jul 13;12(7):e057281. doi: 10.1136/bmjopen-2021-057281.
4
Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies.新型冠状病毒肺炎疫苗引起的速发型超敏反应:当前趋势、潜在机制及预防策略
Biomedicines. 2022 May 28;10(6):1260. doi: 10.3390/biomedicines10061260.
5
Reported Side Effects of COVID-19 Vaccination among Adults in Saudi Arabia: A Cross-Sectional Study.沙特阿拉伯成年人中新冠疫苗接种的报告副作用:一项横断面研究。
SAGE Open Nurs. 2022 Jun 7;8:23779608221103208. doi: 10.1177/23779608221103208. eCollection 2022 Jan-Dec.
6
COVID-19 Vaccination Behavior of People Living with HIV: The Mediating Role of Perceived Risk and Vaccination Intention.艾滋病毒感染者的新冠疫苗接种行为:感知风险和接种意愿的中介作用
Vaccines (Basel). 2021 Nov 6;9(11):1288. doi: 10.3390/vaccines9111288.
截至目前我们对新冠病毒再次感染的了解。
BMJ. 2021 Jan 19;372:n99. doi: 10.1136/bmj.n99.
4
Immunological characteristics govern the transition of COVID-19 to endemicity.免疫特性决定了 COVID-19 向地方病的转变。
Science. 2021 Feb 12;371(6530):741-745. doi: 10.1126/science.abe6522. Epub 2021 Jan 12.
5
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
6
National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020.2020年4月1日至12月8日美国公众接种新冠疫苗可能性的全国趋势
JAMA. 2020 Dec 29;325(4):396-8. doi: 10.1001/jama.2020.26419.
7
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗(阿斯利康)对 SARS-CoV-2 的安全性和有效性:巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
8
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
9
Seasonal coronavirus protective immunity is short-lasting.季节性冠状病毒的保护免疫作用是短暂的。
Nat Med. 2020 Nov;26(11):1691-1693. doi: 10.1038/s41591-020-1083-1. Epub 2020 Sep 14.
10
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.SARS-CoV-2 T 细胞免疫:特异性、功能、持久性及其在保护中的作用。
Sci Immunol. 2020 Jul 17;5(49). doi: 10.1126/sciimmunol.abd6160.